FHA
EPZM

Flagship Harbor Advisors’s Epizyme, Inc EPZM Stock Holding History

Flagship Harbor Advisors’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,500
Closed -$65K – 1926
2020
Q3 		$65K Hold
5,500
– – 0.01% 779
2020
Q2 		$88K Hold
5,500
– – 0.01% 686
2020
Q1 		$85K Buy
+5,500
New +$118K 0.02% 602

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Flagship Harbor Advisors's EPZM Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Epizyme, Inc (EPZM) in Q4 2020, closing a stake of 5,500 shares — an estimated $65K sold.

Flagship Harbor Advisors first reported a position in EPZM in Q1 2020 and held it in 3 quarters. The position peaked at $88K in Q2 2020. 138 funds tracked by Wall St. Rank hold EPZM as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Epizyme, Inc position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 5,500 Epizyme, Inc shares in Q4 2020, an estimated $65K.
  • Flagship Harbor Advisors first reported a position in Epizyme, Inc in Q1 2020 and held it in 3 quarters.
  • Flagship Harbor Advisors's Epizyme, Inc position peaked at $88K in Q2 2020.
  • 138 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.